170 related articles for article (PubMed ID: 9070355)
1. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition.
Pignatello MA; Kauffman FC; Levin AA
Toxicol Appl Pharmacol; 1997 Feb; 142(2):319-27. PubMed ID: 9070355
[TBL] [Abstract][Full Text] [Related]
2. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): interactions with the retinoic acid receptors.
Pignatello MA; Kauffman FC; Levin AA
Toxicol Appl Pharmacol; 1999 Sep; 159(2):109-16. PubMed ID: 10495774
[TBL] [Abstract][Full Text] [Related]
3. Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures: a model to explain the potency of the aromatic retinoid (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-propenyl] benzoic acid.
Pignatello MA; Kauffman FC; Levin AA
Toxicol Appl Pharmacol; 2002 Feb; 178(3):186-94. PubMed ID: 11858735
[TBL] [Abstract][Full Text] [Related]
4. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
Elmazar MM; Reichert U; Shroot B; Nau H
Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
[TBL] [Abstract][Full Text] [Related]
5. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
6. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
Tian K; Norris AW; Lin CL; Li E
Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
[TBL] [Abstract][Full Text] [Related]
7. Specific antagonist of retinoid toxicity in mice.
Standeven AM; Johnson AT; Escobar M; Chandraratna RA
Toxicol Appl Pharmacol; 1996 May; 138(1):169-75. PubMed ID: 8658506
[TBL] [Abstract][Full Text] [Related]
8. Receptor-selective retinoid agonists and teratogenic activity.
Willhite CC; Dawson MI; Reichert U
Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid receptor gamma-induced misregulation of chondrogenesis in the murine limb bud in vitro.
Galdones E; Hales BF
Toxicol Sci; 2008 Nov; 106(1):223-32. PubMed ID: 18703560
[TBL] [Abstract][Full Text] [Related]
10. Comparative disposition, receptor affinity, and teratogenic activity of sulfon arotinoids.
Willhite CC; Dubois A; Schindler-Horvat J; Apfel C; Eckhoff C
Teratology; 1995 Sep; 52(3):169-75. PubMed ID: 8638257
[TBL] [Abstract][Full Text] [Related]
11. Biologically active heteroarotinoids exhibiting anticancer activity and decreased toxicity.
Benbrook DM; Madler MM; Spruce LW; Birckbichler PJ; Nelson EC; Subramanian S; Weerasekare GM; Gale JB; Patterson MK; Wang B; Wang W; Lu S; Rowland TC; DiSivestro P; Lindamood C; Hill DL; Berlin KD
J Med Chem; 1997 Oct; 40(22):3567-83. PubMed ID: 9357524
[TBL] [Abstract][Full Text] [Related]
12. Relative developmental toxicity potencies of retinoids in the embryonic stem cell test compared with their relative potencies in in vivo and two other in vitro assays for developmental toxicity.
Louisse J; Gönen S; Rietjens IM; Verwei M
Toxicol Lett; 2011 May; 203(1):1-8. PubMed ID: 21362465
[TBL] [Abstract][Full Text] [Related]
13. The effects of natural and synthetic retinoids on the differentiation of RCJ C5.18 chondrogenic cells.
Von Schroeder HP; Hashimoto Y; Heersche JN
Teratology; 1994 Jul; 50(1):54-62. PubMed ID: 7974255
[TBL] [Abstract][Full Text] [Related]
14. Endogenous status of retinoids and their cytosolic binding proteins in limb buds of chick vs mouse embryos.
Scott WJ; Walter R; Tzimas G; Sass JO; Nau H; Collins MD
Dev Biol; 1994 Oct; 165(2):397-409. PubMed ID: 7958408
[TBL] [Abstract][Full Text] [Related]
15. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
[TBL] [Abstract][Full Text] [Related]
16. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation.
Thacher SM; Standeven AM; Athanikar J; Kopper S; Castilleja O; Escobar M; Beard RL; Chandraratna RA
J Pharmacol Exp Ther; 1997 Aug; 282(2):528-34. PubMed ID: 9262312
[TBL] [Abstract][Full Text] [Related]
17. Relation of TGF-beta 2 to inhibition of limb bud chondrogenesis by retinoid in rats.
Tsuiki H; Fukiishi Y; Kishi K
Teratology; 1996 Oct; 54(4):191-7. PubMed ID: 9122888
[TBL] [Abstract][Full Text] [Related]
18. [Genetic control of the development by retinoic acid].
Mark M; Kastner P; Ghyselinck NB; Krezel W; Dupé V; Chambon P
C R Seances Soc Biol Fil; 1997; 191(1):77-90. PubMed ID: 9181129
[TBL] [Abstract][Full Text] [Related]
19. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.
Vu-Dac N; Gervois P; Torra IP; Fruchart JC; Kosykh V; Kooistra T; Princen HM; Dallongeville J; Staels B
J Clin Invest; 1998 Aug; 102(3):625-32. PubMed ID: 9691099
[TBL] [Abstract][Full Text] [Related]
20. Placental transfer and developmental effects of 9-cis retinoic acid in mice.
Kochhar DM; Jiang H; Penner JD; Heyman RA
Teratology; 1995 Apr; 51(4):257-65. PubMed ID: 7570368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
